472 related articles for article (PubMed ID: 17353509)
1. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
[TBL] [Abstract][Full Text] [Related]
2. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
[TBL] [Abstract][Full Text] [Related]
3. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.
De Silva DS; Wilson RM; Hutchinson C; Ip PC; Garcia AG; Lancel S; Ito M; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1983-93. PubMed ID: 19395558
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
6. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
8. Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
Krishnamurthy P; Subramanian V; Singh M; Singh K
Hypertension; 2007 Apr; 49(4):865-72. PubMed ID: 17283249
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
Dhahri W; Couet J; Roussel É; Drolet MC; Arsenault M
Life Sci; 2013 Jan; 92(1):26-34. PubMed ID: 23142240
[TBL] [Abstract][Full Text] [Related]
10. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
12. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
[TBL] [Abstract][Full Text] [Related]
16. Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.
Ismael S; Purushothaman S; Harikrishnan VS; Nair RR
Mol Cell Biochem; 2015 Aug; 406(1-2):173-82. PubMed ID: 25976666
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.
Delayre-Orthez C; Becker J; Guenon I; Lagente V; Auwerx J; Frossard N; Pons F
Respir Res; 2005 Aug; 6(1):91. PubMed ID: 16091136
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]